Abstract
Retinoic acid (RA) is essential for gut endoderm development and has been extensively used for in vitro pancreatic differentiation from human pluripotent stem cells. However, the gene regulatory network triggered by RA signaling remains poorly addressed. Also, whether RA signals control histone modifiers such as the Polycomb group proteins during pancreatic specification remains to be explored. Here, we assess the role of RA on pancreas-specific genes during the differentiation of human embryonic stem cells (hESCs). We demonstrate that RA helps cells exit the definitive endoderm stage and proceed toward a pancreatic fate. Inhibition of the RA pathway using the pharmacological inhibitor LE135 impairs the induction of pancreatic endoderm (PE) markers FOXA2, HNF4α, HNF1β, HHEX, and PDX1. We further determine that RA signals alter the expression of epigenetic-associated genes BMI1 and RING1B in the hESC-derived pancreatic progenitors. These findings broaden our understanding of the mechanisms that drive early PE specification.
Acknowledgments
The authors would like to thank Symbiosis Centre for Stem Cell Research (SCSCR), Symbiosis International University for supporting P.P.
Author contributions
Conceptualization & funding acquisition: P.P. and A.K.; methodology, data analysis, and investigation: N.D.; supervision: P.P.; writing – original draft: N.D.; writing – review and editing: P.P. and N.D.
Disclosure statement
No potential conflict of interest was reported by the author(s).